What if IVF didn’t have to mean so many shots? Could a new protocol allow for fewer shots, less office visits, AND be less expensive?
In this episode of Brave & Curious, Dr. Lora Shahine is joined by Dr. Linnea Goodman to answer these questions and more. They review Dr. Goodman’s research into a protocol, not new to the fertility field around the world, but new to most listeners in the United States that has many benefits to IVF patients.
Dr. Linnea Goodman is a board-certified reproductive endocrinologist and infertility specialist. Throughout her career, Dr. Goodman has been dedicated to advancing the field of reproductive medicine through both clinical excellence and innovative research. Currently, Dr. Goodman practices at Virginia Fertility & IVF, where she specializes in minimally invasive office procedures aimed at optimizing fertility outcomes.
In this episode you’ll hear:
[1:16] Meet Dr. Linnea Goodman: reproductive endocrinologist and researcher
[2:24] IVF shots & their necessity
[4:45] Provera Protocol is a game-changer
[14:35] Research & evidence for the Provera Protocol
[22:19] A patient-centered approach
[25:00] Research Outcomes
[27:07] Innovations in IVF: Progestins
[29:32 The patient experience: benefits and side effects of progestins
[32:36 What does the future hold?
Resources mentioned:
http://vafertility.com
Massin N, et al. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update. 2017 Mar 1;23(2):211-220. doi: 10.1093/humupd/dmw047.PMID: 28062551
R Beguería, et al. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial. Hum Reprod. 2019 May 1;34(5):872-880 doi:10.1093/humrep/dez034. PMID: 30927417
Giles J, et al. Medroxyprogeseterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in ooxyte-donation: a randomized controlled trial. Fert Stert 2021;116: 404-412. PMID: 33814126. DOI: 10.1016/j.fertnstert.2021.02.036
Welp A, et al. Oral medroxyprogesterone acetate for the use of ovulation suppression in in vitro fertilization: a cohort trial. Fertil Steril 2024 May;121(5):806-813. PMID: 38253117 DOI: 10.1016/j.fertnstert.2024.01.026
🖤 Stay up to date with my NEWSLETTER:
https://drlorashahine.com/newsletter
🖤 Listen to my PODCAST Baby or Bust anywhere you listen to podcasts
🖤 FOLLOW ME ON:
▫️ INSTAGRAM → / drlorashahine
▫️ TIKTOK → / drlorashahine
▫️TWITTER → / drlorashahine
▫️ FACEBOOK → / drlorashahine
My BLOG and more resources at my website:
https://drlorashahine.com/
My BOOKS
https://drlorashahine.com/books
Also at amazon.com
-----------------------------------
LIKE, COMMENT, AND SUBSCRIBE *
-----------------------------------
ABOUT : Lora Shahine, MD, is a double board certified reproductive endocrinologist and OBGYN currently practicing at Pacific NW Fertility in Seattle, WA. Originally from North Carolina, Dr. Shahine graduated with a Bachelor of Science in biology from Georgetown University in Washington, DC, and completed her training in medical school at Wake Forest University School of Medicine, residency in obstetrics and gynecology at the University of California at San Francisco, and fellowship in reproductive endocrinology and infertility at Stanford University.
As Clinical Assistant Professor at the University of Washington and Director of the Center of Recurrent Pregnancy Loss at Pacific NW Fertility, she is committed to providing excellence in patient care, teaching the next generation of women’s healthcare providers, and continuing research in the fields of fertility and recurrent miscarriage. She has published over 75 peer-reviewed research projects and is an active member of the American Society of Reproductive Medicine, Seattle Gynecology Society, and the Babyquest Fertility Grant organization. Dr. Shahine is an accomplished author including 'Planting the Seeds of Pregnancy: An Integrative Approach to Fertility Care' and best-selling book, 'Not Broken: An Approachable Guide to Miscarriage and Recurrent Pregnancy Loss.'
Whether through her research, books, lectures, or active social media presense Dr. Shahine is passionate about educating on reproductive health and supporting the feritlity community.
DISCLAIMER: The content contained herein is provided for informational and/or entertainment purposes only and not intended as a substitute for advice provided by a healthcare professional. Use the provided information at your own risk. If you have or suspect that you have a medical problem, please contact your health care provider.
#drlorashahine
Информация по комментариям в разработке